Actively Recruiting
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Led by Senthil Sadhasivam · Updated on 2025-12-18
600
Participants Needed
1
Research Sites
432 weeks
Total Duration
On this page
Sponsors
S
Senthil Sadhasivam
Lead Sponsor
E
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this study is to better understand the comprehensive integration of both clinical and genetic factors that will help to identify mothers who could be at an increased risk of poor response to opioid substitution and infants at risk of significant neonatal abstinence syndrome (NAS).
CONDITIONS
Official Title
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater 18 years
- Currently taking Buprenorphine for Opioid Use Disorder and enrolled in a prenatal opioid maintenance program in the antenatal clinic at IU Health University Hospital
- Pregnant with single baby
- Planned delivery at Methodist, University or Riley Hospital
You will not qualify if you...
- Serious maternal medical illness as deemed by study physician or investigator
- Known or suspected major fetal/neonatal congenital abnormalities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UPMC Children's Hospital
Pittsburgh, Pennsylvania, United States, 15224
Actively Recruiting
Research Team
S
Senthil Sadhasivam, MD, MPH
CONTACT
C
Carly Riedmann, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here